HTAi COVID-19 Response
What is the HTAi COVID-19 Reponse?
HTAi has outlined a three point approach for supporting evidence generation collaborations, and policy decision making consistencies, including: a response team to focus on topic-specific areas of interest and potentially lead and develop projects specifically focused on questions of relevance to the HTA community; webinars to support international collaboration and discussions on common current and horizon issues; and online resources to share publicly available content from members.
Read HTAi’s Position Statement on Evidence Standards and Quality Assessment for COVID-19 Therapeutic Interventions.
What does this mean?
COVID-19 HTA Response Team
The HTAi Board of Directors has created an oversight committee, aptly named the COVID-19 HTA Response Team (C-19 HTA Response Team), to oversee the coordination of society collaborative efforts to support evidence collection, appraisal, dissemination, organizational level collaboration, and foresight deliberations.
Their primary objective is to support the global research effort through informed decision making and improving optimal access to care for patients. The secondary objective is to showcase the strength of HTAi’s international networks.
Specifically, the C-19 HTA Response Team will comprise of members delegating and overseeing working groups. The Response Team will ensure that projects add value to the HTA community, and are consistent with the Vision, Mission, and strategic objectives of HTAi. The Response Team will support the flow of information and knowledge sharing across working groups to the Board and Secretariat.
The C-19 HTA Response webinar series will provide a platform for discussion with member-driven content. The webinars will be a mix of plenary-style presentations with open dialogue. Each webinar will be approximately 90-minutes long.
HTAi aims to consider each timezone, and all sessions will be recorded for subsequent viewing.
To enhance information sharing and collaboration, HTAi has provided online resources that may be of interest to the HTA community. All resources are collected from member organizations and partners.
Who is involved?
The C-19 HTA Response Team is Chaired by Iñaki Gutierrez-Ibarluzea, HTAi President. Members include Dan Ollendorf, HTAi Global Policy Forum chair; Leonor Varela-Lema, HTAi Interest Group Steering Committee Chair; Alric Rüther, Scientific Development and Capacity Building Committee Chair; and Chairs from 7 HTAi Interest Groups.
Webinars will feature members of the C-19 HTA Response Team, as well as partner organizations, members-at-large, and requested members of the HTA community.
This project was initiated by WHO Global ECC-19 Partnership Network.
How can you get involved?
Email your Interest Group Chair with projects and topic suggestion ideas.